- Home
- PCG vs DXCM Comparison
PCG vs DXCM Comparison
Compare PCG & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCG
- DXCM
- Stock Information
- Founded
- PCG 1905
- DXCM 1999
- Country
- PCG United States
- DXCM United States
- Employees
- PCG N/A
- DXCM 10300
- Industry
- PCG Power Generation
- DXCM Medical/Dental Instruments
- Sector
- PCG Utilities
- DXCM Health Care
- Exchange
- PCG Nasdaq
- DXCM Nasdaq
- Market Cap
- PCG 37.8B
- DXCM 33.2B
- IPO Year
- PCG N/A
- DXCM 2005
- Fundamental
- Price
- PCG $17.87
- DXCM $85.48
- Analyst Decision
- PCG Buy
- DXCM Strong Buy
- Analyst Count
- PCG 14
- DXCM 18
- Target Price
- PCG $21.25
- DXCM $98.11
- AVG Volume (30 Days)
- PCG 13.4M
- DXCM 4.4M
- Earning Date
- PCG 04-24-2025
- DXCM 05-01-2025
- Dividend Yield
- PCG 0.56%
- DXCM N/A
- EPS Growth
- PCG N/A
- DXCM N/A
- EPS
- PCG 1.09
- DXCM 1.33
- Revenue
- PCG $24,541,000,000.00
- DXCM $4,148,000,000.00
- Revenue This Year
- PCG $6.16
- DXCM $16.61
- Revenue Next Year
- PCG $2.87
- DXCM $15.37
- P/E Ratio
- PCG $16.36
- DXCM $64.34
- Revenue Growth
- PCG 1.91
- DXCM 9.11
- 52 Week Low
- PCG $14.99
- DXCM $57.52
- 52 Week High
- PCG $21.72
- DXCM $132.26
- Technical
- Relative Strength Index (RSI)
- PCG 63.29
- DXCM 68.45
- Support Level
- PCG $16.70
- DXCM $83.64
- Resistance Level
- PCG $17.47
- DXCM $86.85
- Average True Range (ATR)
- PCG 0.39
- DXCM 2.55
- MACD
- PCG 0.05
- DXCM 0.90
- Stochastic Oscillator
- PCG 95.09
- DXCM 91.11
About PCG Pacific Gas & Electric Co.
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision between January 2019 and June 2020. In 2004, PG&E sold its unregulated assets as part of an earlier postbankruptcy reorganization.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.